Migraine with Aura: Clinical Trials

5 trials for Migraine with Aura, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 unknown. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Recruiting 1, Unknown 1
Phase 22Completed 1, Unknown 1

Follow Migraine with Aura: new trials by email Literature Review of Migraine with Aura trials Research Report on Migraine with Aura

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department
Rimegepant, Zavegepant - Migraine, Migraine Disease
Phase 1RecruitingUniversity of South Florida1002026-09-152026-10-27
A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
Dihydroergotamine - Migraine, Migraine With Aura
Phase 1CompletedSatsuma Pharmaceuticals, Inc.362021-03-052022-04-20
A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
Dihydroergotamine - Migraine With Aura, Migraine Without Aura
Phase 1CompletedSatsuma Pharmaceuticals, Inc.462018-09-112019-11-26
Treatment of Chronic Migraine Headaches.
Dexamethasone, Lidocaine, Thiamine cohort - Chronic Migraine Without Aura, Intractable, Migraine With Typical Aura
Phase 1 / Phase 2UnknownCorona Doctors Medical Clinics, Inc.1002017-07-012018-04-04
Botox Injection in Treatment of Chronic Migraine
Botulinum Toxin Type A - Migraine Disorders
Phase 1 / Phase 2CompletedNorwegian University of Science and Technology102015-02-012016-05-23

Narrower conditions

Migraine Disorders (5)  ·  Migraine without Aura (4)  ·  Headache Disorders (1)

Broader conditions

Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Headache Disorders, Primary (5)  ·  Nervous System Diseases (5)  ·  Headache Disorders (4)

Interventions

Dihydroergotamine (2)  ·  Botulinum Toxins, Type A (1)  ·  Dexamethasone (1)  ·  Lidocaine (1)  ·  rimegepant sulfate (1)

Sponsors

Satsuma Pharmaceuticals, Inc. (2)  ·  Corona Doctors Medical Clinics, Inc. (1)  ·  Norwegian University of Science and Technology (1)  ·  University of South Florida (1)

Countries

United States (4)  ·  Norway (1)

Top investigators

Erling A Tronvik, PhD, MD (1)  ·  Faro T. Owiesy, M.D. (1)  ·  Jeffrey A Levy, MD, PhD (1)  ·  Jeffrey Levy, MD (1)

Results publications

PMID 27154997, PMID 31985049, PMID 38413540

NIH funding

2014 (1)